Search research articles
Contact Us
Filters
Showing results (151-160 of 194) with videos related to
Page
of 20
Sort By:
Colloids and Surfaces. B, Biointerfaces
|
September 13, 2021
SERS liquid biopsy: An emerging tool for medical diagnosis
Vlad Moisoiu, Stefania D Iancu, Andrei Stefancu, et al.
Oncotarget
|
September 4, 2018
Correction: Genetically enhanced T lymphocytes and the intensive care unit
Tiberiu Tat, Huming Li, Catalin-Sorin Constantinescu, et al.
Journal of Clinical Medicine
|
August 1, 2020
Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma-Romanian Experience
Alina D Tanase, Andrei Colita, Oana G Craciun, et al.
Frontiers in Oncology
|
July 23, 2020
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
Cristina Turcas, Vlad Moisoiu, Andrei Stefancu, et al.
Journal of Clinical Medicine
|
October 13, 2021
Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma
Dalma Deak-Mihaly, Sabina Iluta, Sergiu Pasca, et al.
Journal of Cellular and Molecular Medicine
|
March 5, 2025
SERS-Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia
Anamaria Bancos, Stefania D Iancu, Vlad Moisoiu, et al.
Frontiers in Oncology
|
July 23, 2020
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
Letitia-Elena Radu, Andrei Colita, Sergiu Pasca, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
January 17, 2021
Baseline characteristics of a nationwide cohort of pediatric patients with acute leukemias of Down syndrome
Valentina Sas, Cristina Blag, Sergiu Pasca, et al.
Journal of Cellular Physiology
|
March 16, 2017
Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis
Ciprian Tomuleasa, Sonia Selicean, Grigore Gafencu, et al.
Journal of Cellular and Molecular Medicine
|
June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
Sabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 194) with videos related to
Sort By:
Page
of 20
Colloids and Surfaces. B, Biointerfaces
|
September 13, 2021
SERS liquid biopsy: An emerging tool for medical diagnosis
Vlad Moisoiu, Stefania D Iancu, Andrei Stefancu, et al.
Oncotarget
|
September 4, 2018
Correction: Genetically enhanced T lymphocytes and the intensive care unit
Tiberiu Tat, Huming Li, Catalin-Sorin Constantinescu, et al.
Journal of Clinical Medicine
|
August 1, 2020
Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma-Romanian Experience
Alina D Tanase, Andrei Colita, Oana G Craciun, et al.
Frontiers in Oncology
|
July 23, 2020
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
Cristina Turcas, Vlad Moisoiu, Andrei Stefancu, et al.
Journal of Clinical Medicine
|
October 13, 2021
Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma
Dalma Deak-Mihaly, Sabina Iluta, Sergiu Pasca, et al.
Journal of Cellular and Molecular Medicine
|
March 5, 2025
SERS-Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia
Anamaria Bancos, Stefania D Iancu, Vlad Moisoiu, et al.
Frontiers in Oncology
|
July 23, 2020
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
Letitia-Elena Radu, Andrei Colita, Sergiu Pasca, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
January 17, 2021
Baseline characteristics of a nationwide cohort of pediatric patients with acute leukemias of Down syndrome
Valentina Sas, Cristina Blag, Sergiu Pasca, et al.
Journal of Cellular Physiology
|
March 16, 2017
Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis
Ciprian Tomuleasa, Sonia Selicean, Grigore Gafencu, et al.
Journal of Cellular and Molecular Medicine
|
June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
Sabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
Page
of 20